7 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2250721/qiagen-qgen-boosts-cancer-research-suite-with-new-launches?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250721
Apr 04, 2024 - QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
zc:6094485797210833628
0
https://seekingalpha.com/article/4669347-qiagen-n-v-qgen-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Feb 11, 2024 - Qiagen N.V. (NYSE:NYSE:QGEN) Q4 2023 Earnings Conference Call February 7, 2024 9:00 AM ETCompany ParticipantsJohn Gilardi - VP, Corporate Communications...
0
sa:6529663081371159520
0
https://www.zacks.com/stock/news/2222219/qiagen-qgen-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2222219
Feb 06, 2024 - Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-6044007974713674186
0
https://www.zacks.com/stock/news/2209391/qiagen-qgen-wins-fda-clearance-for-neumodx-ct-ng-assay?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209391
Jan 12, 2024 - QIAGEN (QGEN) receives FDA clearance for the NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 versions of the integrated PCR-based clinical molecular testing system.
zc:-5585332516778461624
0
https://www.zacks.com/stock/news/2207546/qiagen-qgen-gains-from-new-alliances-amid-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-2207546
Jan 09, 2024 - QIAGEN (QGEN) is progressing well with its testing menu expansion strategy, which is driving the company's growth.
zc:7025992600839157637
0
https://www.zacks.com/stock/news/2203003/here-s-why-you-should-retain-qiagen-qgen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203003
Dec 28, 2023 - Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena.
zc:6078928719126040644
0
https://www.zacks.com/stock/news/2197534/qiagen-s-qgen-strategic-alliances-aid-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2197534
Dec 13, 2023 - QIAGEN (QGEN) aims to expand the NGS platform by rapidly scaling up the new Enterprise Genomics Services.
zc:-5644634777116988695
0